Recent Updates
Recently added Catalysts
PRAX Positive Sentiment

Praxis Precision Medicines to Participate in Upcoming Fireside Chat

Thursday, November 20, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Praxis Precision Medicines, Inc. has announced its participation in an upcoming fireside chat hosted by HCWainwright analyst Doug Tsao. The session will focus on a deep dive into the data related to their therapeutic, Ulixacaltamide, with guest statistician Prof. Chuck McCullogh from UC San Francisco. CEO Marcio Souza will also take part in this informative discussion scheduled for November 24, 2025.
Price reaction · baseline $189.32 (2025-11-19 close) · hit after-hours · 1 other PRAX headline(s) in the window, move may be shared
day 0 close · peak
-13.3%
day 1
-10.3%
day 3
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Praxis is participating in an expert call that may enhance their visibility.
  • The involvement of the CEO Marcio Souza represents strong company leadership.
  • Collaboration with a statistician from UC San Francisco adds credibility to the data discussion.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+61%
120-day peak, hindsight
Typical move
23.7%
average across 12 past catalysts
Cash runway
~53 mo
Minimal dilution risk
Lead asset
vormatrogine
Phase 3 · Epilepsy, Tonic-Clonic

Full Press Release Details

BOSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that HCWainwright analyst Doug Tsao will host an expert call on Deep Dive into Praxis’ Ulixacaltamide Data with statistician Prof. Chuck McCullogh, University of California, San Francisco on November 24, 2025 at 1:00pm EST which will be joined by Marcio Souza, Praxis’ CEO.
The registration link can be found here.

Frequently Asked Questions

What company is hosting an expert call on Ulixacaltamide data?

Praxis Precision Medicines, Inc. is hosting the expert call.

Who will join the expert call on Ulixacaltamide?

Marcio Souza, CEO of Praxis, will join the expert call.

When is the expert call scheduled?

The expert call is scheduled for November 24, 2025, at 1:00pm EST.

Who is the statistician featured in the expert call?

Prof. Chuck McCullogh from UCSF will participate in the expert call.

What is the focus of Praxis Precision Medicines?

They focus on therapies for CNS disorders due to neuronal imbalance.

ShareAdd on Google
Tags: PRAX Viatris Investor Conferences Healthcare Ulixacaltamide CNS disorders Marcio Souza expert call
Last updated: Nov 20, 2025

Biotech snapshot

Cash runway
$1374M liquidity · $26M/mo burn
~53 mo
Minimal dilution risk
Lead asset
vormatroginePhase 3
Epilepsy, Tonic-Clonic →

Catalyst track record

+61%
best trade around PRAX's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for PRAX.

See every catalyst's timing & PoA →